Question 1

Does UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS own ARWR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS holds 964,479 shares of ARWR (Arrowhead Pharmaceuticals in), worth $78.6M.

Question 2

How many shares of ARWR does UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS own?

Accepted Answer

As of its Q2 2026 13F, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS holds 964,479 shares of ARWR (Arrowhead Pharmaceuticals in).

Question 3

What is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS' ARWR position worth?

Accepted Answer

As of its Q2 2026 13F, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS' ARWR position is worth $78.6M.

Question 4

Is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS buying or selling ARWR?

Accepted Answer

In Q2 2026, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS reduced its ARWR position by 366,517 shares (-27.5%).

Question 5

When did UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS first buy ARWR?

Accepted Answer

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS already held ARWR in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	964,479	-27.5%	$78.6M	0.0%	$81.51	0
2026-Q1	Increased	1.3M	+5.6%	$83.5M	0.0%	$62.70	31
2025-Q4	Decreased	1.3M	-28.4%	$83.7M	0.0%	$66.39	0
2025-Q3	Decreased	1.8M	-34.5%	$60.7M	0.0%	$34.49	0
2025-Q2	Decreased	2.7M	-43.9%	$42.4M	0.0%	$15.80	0
2025-Q1	Increased	4.8M	+138.1%	$61M	0.0%	$12.74	48
2024-Q4	Decreased	2M	-6.7%	$37.8M	0.0%	$18.80	0
2024-Q3	Decreased	2.2M	-5.9%	$41.7M	0.0%	$19.37	0